Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson's disease. 2010

Farhad Mashayekhi, and Ebrahim Mirzajani, and Mohammad Naji, and Majid Azari
Department of Biology, Faculty of Sciences, University of Guilan, Namjoo Street, PO Box 1914, Rasht, Iran. umistbiology@yahoo.co.uk <umistbiology@yahoo.co.uk>

Parkinson's disease (PD) is characterized by progressive loss of dopaminergic neurons in the substantia nigra. Insulin like growth factor-1 (IGF-1) promotes the survival of dopaminergic neurons and protects them from toxin-induced damage in vitro. IGF-1 is produced by a wide variety of cells and is found in many physiological fluids, including cerebrospinal fluid (CSF). IGFs in physiological fluids are associated with insulin-like growth factor binding proteins (IGFBPs), which bind to them and modulate their bioactivity at the cellular level. Since the CSF is in contact with the extracellular space of the brain, biochemical brain modifications are, to some extent, reflected in the CSF, and peptides and growth factors in the CSF can be used as biomarkers of PD. The aim of this study was to determine the concentrations of IGF-1 and IGFBPs in the serum and CSF of patients with PD. Concentrations were measured in a total of 76 CSF samples from patients with PD (n=38) and controls (n=38). Serum and CSF IGF-1 and IGFBP concentrations were higher in patients with PD than in controls (p<0.001). We conclude that IGF-1 and IGFBPs are always present in human serum and CSF, and may be involved in the pathophysiology of PD.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D018969 Insulin-Like Growth Factor Binding Proteins A family of soluble proteins that bind insulin-like growth factors and modulate their biological actions at the cellular level. (Int J Gynaecol Obstet 1992;39(1):3-9) IGF Binding Protein,IGF-Binding Protein,IGF-Binding Proteins,IGFBP,Insulin-Like Growth Factor Binding Protein,Somatomedin-Binding Protein,Somatomedin-Binding Proteins,Binding Protein, IGF,IGF Binding Proteins,Insulin Like Growth Factor Binding Protein,Protein, IGF Binding,Protein, IGF-Binding,Protein, Somatomedin-Binding,Somatomedin Binding Protein,Somatomedin Binding Proteins

Related Publications

Farhad Mashayekhi, and Ebrahim Mirzajani, and Mohammad Naji, and Majid Azari
January 2008, BioFactors (Oxford, England),
Farhad Mashayekhi, and Ebrahim Mirzajani, and Mohammad Naji, and Majid Azari
January 1993, Journal of neural transmission. Parkinson's disease and dementia section,
Farhad Mashayekhi, and Ebrahim Mirzajani, and Mohammad Naji, and Majid Azari
July 2009, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Farhad Mashayekhi, and Ebrahim Mirzajani, and Mohammad Naji, and Majid Azari
October 2007, Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES,
Farhad Mashayekhi, and Ebrahim Mirzajani, and Mohammad Naji, and Majid Azari
January 2018, Frontiers in endocrinology,
Farhad Mashayekhi, and Ebrahim Mirzajani, and Mohammad Naji, and Majid Azari
December 2010, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Farhad Mashayekhi, and Ebrahim Mirzajani, and Mohammad Naji, and Majid Azari
November 1999, Biochemical and biophysical research communications,
Farhad Mashayekhi, and Ebrahim Mirzajani, and Mohammad Naji, and Majid Azari
November 2002, The Journal of urology,
Farhad Mashayekhi, and Ebrahim Mirzajani, and Mohammad Naji, and Majid Azari
November 1996, Journal of hepatology,
Farhad Mashayekhi, and Ebrahim Mirzajani, and Mohammad Naji, and Majid Azari
March 2010, European journal of neurology,
Copied contents to your clipboard!